PI
OBIO icon

Putnam Investments’s Orchestra BioMed OBIO Stock Holding History

Putnam Investments’s Portfolio OBIO Stock Details OBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-750,000
Closed -$7.5M – 1235
2021
Q4 		$7.5M Hold
750,000
– – 0.01% 446
2021
Q3 		$7.42M Hold
750,000
– – 0.01% 433
2021
Q2 		$7.65M Hold
750,000
– – 0.01% 429
2021
Q1 		$8.42M Hold
750,000
– – 0.01% 406
2020
Q4 		$9.61M Hold
750,000
– – 0.02% 375
2020
Q3 		$8.25M Buy
+750,000
New +$8.42M 0.02% 371

Other funds holding OBIO

DKCM
Davidson Kempner Capital Management New York $4.65B AUM 56.47% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SCM
Saba Capital Management New York $3.12B AUM 13% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AC
Amitell Capital Singapore $62.4M AUM 75.98% 1-Year Est. Return
SC
Sculptor Capital New York $8.88B AUM 27.49% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return